Literature DB >> 25140751

Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii.

Melissa D'Ascenzio1, Bruna Bizzarri2, Celeste De Monte1, Simone Carradori1, Adriana Bolasco1, Daniela Secci1, Daniela Rivanera3, Nathan Faulhaber4, Claudia Bordón4, Lorraine Jones-Brando4.   

Abstract

We designed and synthesized a large number of novel thiazolidin-4-one derivatives for the evaluation of their anti-Toxoplasma gondii activity. This scaffold was functionalized at the N1-hydrazine portion with aliphatic, cycloaliphatic and (hetero)aromatic moieties. Then, a benzyl pendant was introduced at the lactamic NH of the core nucleus to evaluate the influence of this chemical modification on biological activity. The compounds were subjected to several in vitro assays to assess their anti-parasitic efficacy, cytotoxicity on fibroblasts, inhibition of tachyzoite invasion/attachment and replication after treatment. Results showed that fourteen of these thiazole-based compounds compare favorably to control compound trimethoprim in terms of parasite growth inhibition.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Host cell invasion; Parasite growth inhibition; Thiazolidin-4-one; Toxoplasma

Mesh:

Substances:

Year:  2014        PMID: 25140751     DOI: 10.1016/j.ejmech.2014.08.046

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

Review 1.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 2.  A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).

Authors:  Mahbobeh Montazeri; Mehdi Sharif; Shahabeddin Sarvi; Saeed Mehrzadi; Ehsan Ahmadpour; Ahmad Daryani
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

3.  A facile synthesis and antimicrobial activity evaluation of sydnonyl-substituted thiazolidine derivatives.

Authors:  Mei-Hsiu Shih; Yu-Yuan Xu; Yu-Sheng Yang; Guan-Ling Lin
Journal:  Molecules       Date:  2015-04-13       Impact factor: 4.411

4.  Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18.

Authors:  Diego Molina; Rodrigo Cossio-Pérez; Cristian Rocha-Roa; Lina Pedraza; Edwar Cortes; Alejandro Hernández; Jorge E Gómez-Marín
Journal:  BMC Genomics       Date:  2018-11-29       Impact factor: 3.969

5.  Urazolium diacetate as a new, efficient and reusable Brønsted acid ionic liquid for the synthesis of novel derivatives of thiazolidine-4-ones.

Authors:  Leila Zare Fekri; Hooshang Hamidian; Masoomeh Abdollahi Chekosarani
Journal:  RSC Adv       Date:  2020-01-02       Impact factor: 4.036

6.  Dimroth-type N/S-interchange of N-aminothioglycolurils in the synthesis of 2-hydrazonoimidazo[4,5-d]thiazolones.

Authors:  Ekaterina E Vinogradova; Galina A Gazieva; Alexei N Izmest'ev; Valentina A Karnoukhova; Angelina N Kravchenko
Journal:  RSC Adv       Date:  2021-08-23       Impact factor: 3.361

7.  Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors.

Authors:  Özlen Güzel-Akdemir; Andrea Angeli; Kübra Demir; Claudiu T Supuran; Atilla Akdemir
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

8.  A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis.

Authors:  Cristian Rocha-Roa; Diego Molina; Néstor Cardona
Journal:  Front Cell Infect Microbiol       Date:  2018-10-16       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.